Grape King Bio Ltd. · TWSE:1707
Grape King Bio — Investor Presentation (September 2026)
31 slides from Grape King Bio's investor presentation, Sep 17, 2026
Slide 1: Grape King Bio (1707 TT) Investor Presentation
Grape King Bio (1707 TT) Investor Presentation Sep 17, 2026
Slide 2: Company Milestone
Company Milestone Uni-President (1216 TT) Pro-Partner ranked No. 38 became a shareholder and among worldwide direct Grape King Longtan UVACO was Grape King Bio-Tech Taiepi Grape King Sales strategic partner through a HQ was established selling company Plant in Zhongli established HQ in Pingzhen priv
Slide 3: 2026 H1 Results
iG! fal selt FIX 2026 H1 Results
Slide 4: Company Overview: Three core business units
Company Overview: Three core business units 4 1. Taiwan Grape King (Parent Co) 2026 H1 Revenue 2026 H1 Net Profit Grape King Taiwan own brand & global OEM/ODM Taiwan Focus of all key ingredient design, formulation, and production for UVACO the whole Group. 12% -2% 10% 15% Grape King 2. UVACO (60%-ow
Slide 5: 2026 H1 Revenue Declined by 2.7%
2026 H1 Revenue Declined by 2.7% 5 Revenue NT$mn 6,000 -2.7% 4,821 5,000 4,692 -6.7% 4,000 3,682 3,434 3,000 2,000 +6.9% +14.8% 1,000 634 678 580 505 0 2025H1 2026H1 Taiwan Grape King Shanghai Grape King UVACO Consolidated 2026 H1 Revenue Declined by NT$129mn（ Taiwan Grape King +44mn , Shanghai Grap
Slide 6: 2026 H1 EPS
2026 H1 EPS 6 Cumulative EPS (NT$) 1Q 1Q-2Q 1Q-3Q 1Q-4Q 2024 1.74 3.95 6.76 9.78 2025 1.40 3.22 5.22 8.22 2026 1.18 2.75
Slide 7: Income Statement
Income Statement 7 (NT$ mn) 2021 2022 2023 2024 2025 2025 H1 2026 H1 YoY(%) Revenue 9,798 10,391 10,635 11,160 10,252 4,821 4,692 -2.7% Gross Profit 7,855 8,481 8,534 8,658 7,698 3,613 3,352 -7.2% Operating Expenses (5,543) (5,929) (6,037) (6,158) (5,556) -2,759 -2,604 -5.6% Operating Profit 2,312 2
Slide 8: Dividend Payout and Capex
Dividend Payout and Capex 8 (NT$ mn) 2021 2022 2023 2024 2025 2026 Net Profit 1,300 1,457 1,453 1,448 1,218 - Cash Dividend 904 1,022 1,022 1,022 889 - Cash DPS (NT$) 6.1 6.9 6.9 6.9 6.0 - Payout Ratio 69.2% 70.1% 70.3% 70.6% 73.0% 70.0% (*planned) EPS (NT$) 8.81 (*1) 9.84 9.81 9.78 8.22 Capex 1,481
Slide 9: Balance Sheet
Balance Sheet 9 (NT$mn) 2021 2022 2023 2024 2025 2026 H1 Total Assets 14,061 15,053 15,512 15,324 15,738 15,002 Cash 3,635 4,673 4,819 4,343 4,165 3,539 AR &NR 301 270 291 305 337 336 Inventories 719 688 688 754 829 812 Fixed Assets 7,208 7,360 7,539 7,699 7,841 7,736 Total Liabilities 3,632 3,912 3
Slide 10: 1. Taiwan Grape King
1. Taiwan Grape King deaths
Slide 11: Grape King Taiwan – Business Overview
Grape King Taiwan – Business Overview NT$mn Grape King Taiwan Sales (Own brand + ODM/OEM) 1,500 1,370 +16% 11 +13% -5% 1,247 1,179 YoY 1,300 YoY YoY +21% 1,104 YoY 1,100 914 900 700 678 +7% 500 YoY 300 2021 2022 2023 2024 2025 2026 H1
Slide 12: Grape King Taiwan – Own Brand Business Overview
Grape King Taiwan – Own Brand Business Overview 12 NT$mn Grape King Taiwan Own brand Sales 900 +14% 840 YoY +12% 737 716 YoY 658 -15% 657 YoY 600 -8% YoY 300 308 -3% YoY 0 2021 2022 2023 2024 2025 2026 H1
Slide 13: Grape King Taiwan – OEM/ODM Business Overview
Grape King Taiwan – OEM/ODM Business Overview 13 NT$mn Grape King Taiwan ODM/OEM Sales 800 713 700 +54% YoY 600 +14% 500 YoY 463 +11% YoY 407 400 +44% 367 YoY 370 300 255 +16% YoY 200 2021 2022 2023 2024 2025 2026 H1
Slide 14: Grape King Taiwan – 2026 H1 OEM/ODM Performance
Grape King Taiwan – 2026 H1 OEM/ODM Performance 14 2025 H1 2026 H1 16% 2026 H1 PIC/S, P 17% Customer, P 47% Customer, PIC/S, 9% Raw 30% Materials 318 M 370 M 22% Raw materials Finished Goods, 22% Finished Goods, 22% 31%
Slide 15: Grape King Reishi Botanical Drug – FDA-Approved for Phase II Clinical Trial
Grape King Reishi Botanical Drug – FDA-Approved for Phase II Clinical Trial 15 • Reishi (Antrodia camphorata), known as Taiwan’s “Ruby of the Forest,” is recognized for its protective and anti-fatigue properties. • Grape King has over 20 years of Reishi R&D, holding multiple efficacy studies and pat
Slide 16: 2. UVACO
T) <q 2. UWVACO
Slide 17: UVACO Overview – Key Numbers
UVACO Overview – Key Numbers 17 2 Taiwan’s Second Largest 3 Taiwan’s Third Largest Local Direct Sales Company Direct Sales Company (Based on Revenue Rankings) (2025 Market Share: 9.42%) 54 Products, including health supplements, skincare solutions & oral care essentials
Slide 18: UVACO Revenue
UVACO Revenue 18 2026 H1 -6.8% YoY 2025 +7.8% -6.8% -10.4% -7.1% -10.4% -9.4% 2026 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec (NT$mn) Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan-Jun 2025 487.5 457.4 733.1 669.7 656.4 677.5 564.0 649.2 596.8 859.5 894.4 630.4 3,681.7 2026 525.3 426.
Slide 19: Update on UVACO Skincare Products
Update on UVACO Skincare Products 19 Unit：NT$mn 500 +26% 472 7.0% YoY 450 +7% 6.0% 400 YoY 375 350 6.0% 350 5.0% 300 4.0% 4.2% 265 250 4.1% +17.0% 3.0% 200 YoY Revenue Contribution % to UVACO 150 2.0% 100 1.0% 50 6 SKUs 6 SKUs 11 SKUs 11 SKUs 0 0.0% 2023 2024 2025 2026H1 2026 H1 Revenue NT$265mn, ac
Slide 20: Pro-Partner rebranded to UVACO for Global Expansion
Pro-Partner rebranded to UVACO for Global Expansion 20 • Pro-Partner has now been rebranded to “UVACO”, as we initiate a brand revamp while simultaneously advancing our global operational footprint. • Obtained the Malaysian Direct Selling License (AJL License) in February 2026. • In August 2026, UVA
Slide 21: 3. Shanghai Grape King
iT) jj 3. Shanghai Grape King dah
Slide 22: Shanghai Grape King GMP
Shanghai Grape King Plant Size Covers area of 170 hectares GMP Plant of 12,500 sqm GMP 10k-level qualified manufacturing site manufacturing plant (Compliant with health (Liquid filling food product and 10k-level) safety standards)
Slide 23: China Business Update
China Business Update Grape King Shanghai Revenue Breakdown In response to China’s relatively sluggish Smart Vending Machine, 3% economy OEM/ODM, 26% Three Major Strategies: 1. Maintain OEM/ODM ↓ 2. Expand Distribution Distribution, 71% 3. Deploy Smart Vending Machines Smart Vending Machine OEM/ODM
Slide 24: China Distribution Business
China Distribution Business 24 • Current primary focus: Uni-President instant noodles & beverages. • Ongoing expansion: Well-known Chinese beverage & snack brands
Slide 25: Smart Vending Machines
Smart Vending Machines =) Fc A (8 ill 16:15 | sma 20 j = B7K En Aba rh ce Be + Fes roy os (ee) EEE Bats C4HAKUREGDIGGL
Slide 26: Plans and Strategies
Plans and Strategies
Slide 27: Outlook
Outlook 27 • UVACO ： • Kuala Lumpur Operations Center official launched on August 17. • Initial launch includes six flagship Taiwan products. 30 products to be launched within the next 2 years via the UVACO ASEAN network. • Topical Products: Transitioning from “Personal Care” to a “Comprehensive Lif
Slide 28: UVACO – Malaysia Operation Center
UVACO – Malaysia Operation Center 28 • ASEAN population: 680mn • Muslim Consumer Market • Southeast Asian Hub
Slide 29: UVACO – Pre-Launch Market Briefing
UVACO – Pre-Launch Market Briefing 29 Over thousands 1000+ !! participants of participants with new members recruit in progress
Slide 30: UVACO – Malaysia Official Launch on Aug. 17
UVACO – Malaysia Official Launch on Aug. 17 30 300+ VIP Guests (Including the Minister of the Taipei Economic and Cultural Office in Malaysia, the President of the Direct Selling Association of Malaysia, and the Director of the Taiwan Trade Center, Kuala Lumpur)
Slide 31: Thank You!
Thank You! For more information, please visit our website： www.grapeking.com.tw 31
Grape King Bio — Investor Presentation (September 2026) on 6ix